A South Korean company is looking for a business opportunity with partners from the Association of Southeast Asian Nations (Asean) to help develop the regional market for its Covid-19 vaccine.

"We are eyeing partners in the Asean market which has a combined population of more than 680 million," said Kim Young-suk, head of SK Bioscience´s Strategy Department. 

Mr Kim said the company is expanding its business into the region by focusing on people´s ability to access health security and increase the region´s capacity to develop its own vaccines to fight any future...